---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-301902"
form_type: "8-K"
ticker: "ERAS"
cik: "0001761918"
company_name: "Erasca, Inc."
filed_at: "2022-12-09T23:59:59+00:00"
generated_at: "2026-06-21T06:52:04.383041+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Erasca (ERAS) prices $100M public offering and issues $80M stock to Novartis under license

## Summary
- Underwritten offering of 15,384,616 shares at $6.50/share; net proceeds ~$94.7M; expected close Dec 13, 2022.
- Private placement to Novartis of 12,307,692 shares at $6.50/share as partial consideration for exclusive license agreement.
- J.P. Morgan and Goldman Sachs are joint book-running managers for the public offering.
- Proceeds to fund R&D of RAS/MAPK pathway programs and general corporate purposes.

## SEC filing metadata
- accession: 0001193125-22-301902
- form_type: 8-K
- ticker: ERAS
- cik: 0001761918
- company_name: Erasca, Inc.
- filed_at: 2022-12-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1761918/000119312522301902/0001193125-22-301902-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1761918/000119312522301902/d435484d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-301902
- JSON: https://secwatch.observer/filing/0001193125-22-301902.json
- Plain text: https://secwatch.observer/filing/0001193125-22-301902.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.